These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1173516)

  • 1. On the interaction between caffeine and barbiturates with respect to locomotor activity and brain catecholamines.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):172-80. PubMed ID: 1173516
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethanol and caffeine: a complex interaction with respect to locomotor activity and central catecholamines.
    Waldeck B
    Psychopharmacologia; 1974 Apr; 36(3):209-20. PubMed ID: 4846326
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of caffeine on locomotor activity and central catecholamine mechanisms: a study with special reference to drug interaction.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 4):1-23. PubMed ID: 1080339
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of piribedil (ET495) on components of locomotor activity.
    Jenner P; Marsden CD
    Eur J Pharmacol; 1975 Aug; 33(1):211-5. PubMed ID: 1175688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization by caffeine of central catecholamine receptors.
    Waldeck B
    J Neural Transm; 1973; 34(1):61-72. PubMed ID: 4714594
    [No Abstract]   [Full Text] [Related]  

  • 6. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 9. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential biochemical mechanisms mediate locomotor stimulation effects by caffeine and nicotine in rats.
    Lee EH; Tsai MJ; Tang YP; Chai CY
    Pharmacol Biochem Behav; 1987 Feb; 26(2):427-30. PubMed ID: 3033699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of clonidine with dopamine-dependent behaviour in rodents.
    Pycock CJ; Jenner PG; Marsden CD
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
    Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
    Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
    Strömberg U; Waldeck B
    J Neural Transm; 1973; 34(4):241-52. PubMed ID: 4359657
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of the locomotor activity effects of apomorphine and the "atypical dopamine agonists" (piribedil and S3608).
    Offermeier J; van Rooyen JM
    Life Sci; 1986 Mar; 38(10):895-903. PubMed ID: 3081774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacologia; 1973; 29(4):289-98. PubMed ID: 4707021
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.
    Engström G; Svensson TH; Waldeck B
    Brain Res; 1974 Sep; 77(3):471-83. PubMed ID: 4855210
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 20. Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine.
    Andén NE; Jackson DM
    J Pharm Pharmacol; 1975 Sep; 27(9):666-70. PubMed ID: 241810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.